This inventor holds 3 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Korea Research Institute of Bioscience and Biotechnology. Active years: 2020-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2025
Title: Ha Young Choi: Innovator in Neurodegenerative Disease Treatment
Introduction
Ha Young Choi is a prominent inventor based in Daejeon, South Korea. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment and prevention of neurodegenerative diseases. With a total of 3 patents to her name, her work is paving the way for innovative therapeutic solutions.
Latest Patents
One of her latest patents is a composition for preventing or treating neurodegenerative diseases, which contains a diterpene-based compound. This invention relates to a pharmaceutical composition that can prevent or treat neurodegenerative diseases by activating Nurr1 and inhibiting the inflammatory response. Another notable patent involves a pharmaceutical composition and health functional food that includes a flower extract as an active ingredient. This composition is designed to prevent or treat neurodegenerative diseases and is free from genotoxicity, offering superior prophylactic or treatment effects compared to traditional extracts.
Career Highlights
Ha Young Choi is affiliated with the Korea Research Institute of Bioscience and Biotechnology. Her work at this esteemed institution has allowed her to focus on groundbreaking research that addresses critical health issues related to neurodegenerative diseases.
Collaborations
She collaborates with notable colleagues, including Baek Soo Han and Won Gon Kim, who contribute to her research efforts and innovations in the field.
Conclusion
Ha Young Choi's innovative work in the pharmaceutical industry highlights her commitment to advancing treatments for neurodegenerative diseases. Her contributions are essential in the ongoing fight against these challenging health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
